Viewing Study NCT06268860

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:07 AM
Ignite Modification Date: 2026-02-23 @ 1:12 AM
Study NCT ID: NCT06268860
Status: COMPLETED
Last Update Posted: 2025-12-23
First Post: 2024-02-13
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Assess Bioavailability of Rocatinlimab (AMG 451) Vial and Prefilled Syringe in Healthy Participants
Sponsor: Amgen
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Atopic Dermatitis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Rocatinlimab View
None AMG 451 View
None Dermatology View
None Pharmacokinetics View
None Safety View